BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Overview Fund Activity
Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

3 hedge funds and large institutions have $5.52M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JCI
1
Jet Capital Investors
New York
$5.52M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
JCI
1
Jet Capital Investors
New York
$5.52M 2,761,301 +100,000 +4%
MAM
2
Meeder Asset Management
Ohio
$0 5 – –
BCM
3
Beddow Capital Management
Wyoming
$0 572,879 – –